[1]
|
Haram, K., Svendsen, E. and Abildgaard, U. (2009) The HELLP syndrome: Clinical issues and management. A review. BMC Pregnancy Childbirth, 9, 8.
doi:10.1186/1471-2393-9-8
|
[2]
|
Yamamoto, M., Nojima, M., Ohara, M., Suzuk, C., Naishiro, Y., Itoh, Y., Yamamoto, H., Takahashi, H., Kitajima, Y., Endo, T. and Imai, K. (2004) A case of systemic lupus erythematosus with postpartum hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome and concomitant high phosphatidylserine-dependent antiprothrombin antibody levels. Modern Rheumatology, 14, 402-405. doi:10.1007/s10165-004-0331-4
|
[3]
|
Yamada, H., Kishida, T., Kobayashi, N., Kato, E.H., Hoshi, N. and Fujimoto, S. (1998) Massive immunoglobulin treatment in women with four or more recurrent spontaneous primary abortions of unexplained aetiology. Human Reproduction, 13, 2620-2623.
|
[4]
|
Epiney, M., Boehlen, F., Boulvain, M., Reber, G., Antonelli, E., Morales, M., Irion, O. and De Moerioose, P. (2005) D-dimer levels during delivery and the postpartum. Journal of Thrombosis and Haemostasis, 3, 268-271.
doi:10.1111/j.1538-7836.2004.01108.x
|
[5]
|
Hughes, G.R. (183) Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. British Medical Journal, 287, 1088-1089. doi:10.1136/bmj.287.6399.1088
|
[6]
|
Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R., Triplett, D.A. and Khamashta, M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis & Rheumatism, 42, 1309-1311.
doi:10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
|
[7]
|
Lockshin, M.D., Sammaritano, L.R. and Schwartzman, S. (2000) Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis & Rheumatism, 43, 440-443.
doi:10.1002/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N
|
[8]
|
Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derkesen, R.H., Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyyiannopoulos, P.G. and Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306. doi:10.1111/j.1538-7836.2006.01753.x
|
[9]
|
Oku, K., Atsumi, T., Amengual, O. and Koike, T. (2008) Antiprothrombin antibody testing: detection and clinical utility. Seminars in Thrombosis and Hemostasis, 34, 335-339. doi:10.1055/s-0028-1085475
|
[10]
|
Amengual, O., Atsumi, T. and Koike, T. (2003) Specificities, properties, and clinical significance of antiprothrombin antibodies. Arthritis & Rheumatism, 48, 886-895.
doi:10.1002/art.10831
|
[11]
|
Lim, W., Crowther, M.A. and Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: A systematic review. The Journal of American Medical Association, 295, 1050-1057. doi:10.1001/jama.295.9.1050
|
[12]
|
Ruiz, I.G. and Khamashta, M.A. (2005) Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Annals of the New York Academy of Sciences, 1051, 606-612.
doi:10.1196/annals.1361.105
|
[13]
|
D’Cruz, D.P., Khamashta, M.A. and Hughes, G.R. (2007) Systemic lupus erythematosus. Lancet, 369, 587-596.
doi:10.1016/S0140-6736(07)60279-7
|
[14]
|
Ruiz, I.G., Khamashta, M.A., Castellino, G. and Hughes, G.R. (2001) Systemic lupus erythematosus. Lancet, 357, 1027-1032. doi:10.1016/S0140-6736(00)04239-2
|
[15]
|
McClain, M.T., Arbuckle, M.R., Heinlen, L.D., Dennis, G.J., Roebuck, J., Rubertone, M.V., Harley, J.B. and James, J.A. (2004) The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis & Rheumatism, 50, 1226-1232. doi:10.1002/art.20120
|
[16]
|
Hochberg, M.C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism, 40, 17-25. doi:10.1002/art.1780400928
|
[17]
|
Gourley, M.F., Austin, H.A. II, Scott, D., Yarboro, C.H., Vaughan, E.M., Muir, J., Boumpas, D.T., Klippel, J.H., Balow, J.E. and Steinberg, A.D. (1996) Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Annals of Internal Medicine, 125, 549-557.
|
[18]
|
Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. and Hughes, G.R. (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. The New England Journal of Medicine, 332, 993-997.
doi:10.1056/NEJM199504133321504
|
[19]
|
Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M. and Kovacs, M.J. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. The New England Journal of Medicine, 349, 1133-1138.
doi:10.1056/NEJMoa035241
|
[20]
|
Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J., Baudo, F., Berrettini, M., Testa, S., D’Angelo, A., Tognoni, G. and Barbui, T. (2005). A randomized clinical trial of high-intensity warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis, 3, 848-853. doi:10.1111/j.1538-7836.2005.01340.x
|
[21]
|
Kazatchkine, M.D. and Kaveri, S.V. (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. The New England Journal of Medicine, 345, 747-755.
doi:10.1056/NEJMra993360
|
[22]
|
Schroeder, J.O., Zeuner, R.A., Euler, H.H. and Loffler, H. (1996) High dose intravenous immunoglobulins in systemic lupus erythematosus: Clinical and serological results of a pilot study. Journal of Rheumatology, 23, 71-75.
|
[23]
|
Levy, Y., Sherer, Y., Ahmed, A., Langevitz, P., George, J., Fabbrizzi, F., Terryberry, J., Meissner, M., Lorber, M., Peter, J.B. and Shoenfeld Y. (1999) A study of 20 SLE patients with intravenous immunoglobulin—Clinical and serologic response. Lupus, 8, 705-712.
doi:10.1191/096120399678841007
|
[24]
|
Hutton, B., Sharma, R., Fergusson, D., Tinmouth, A., Hebert, P., Jamieson, J. and Walker, M. (2007) Use of intravenous immunoglobulin for treatment of recurrent miscarriage: A systematic review. An International Journal of Obstetrics & Gynaecology, 114, 134-142.
|
[25]
|
Morikawa, M., Yamada, H., Kato, E.H., Shimada, S., Kishi, T., Yamada, T., Kobashi, G. and Fujimoto, S. (2001) Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: Down-regulation of NK cell activity and subsets. American Journal of Reproductive Immunology, 46, 399-404.
doi:10.1034/j.1600-0897.2001.d01-31.x
|
[26]
|
Samuelsson, A., Towers, T.L. and Ravetch, J.V. (2001) Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science, 291, 484-486.
doi:10.1126/science.291.5503.484
|